Quick Links: Skip to main page content Skip to Search Skip to Topics Menu Skip to Section Content Menu Skip to Common Links
  • Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

Vaccines, Blood & Biologics

  • Print
  • Share
  • E-mail

Section Contents Menu

Vaccines

-

Major Amendment letter - Flublok

DEPARTMENT OF HEALTH & HUMAN SERVICES                                                     Public Health Service
 

                                                                                                                            Food and Drug Administration
Rockville, MD 20852-1448

 

Our STN: BL 125285/0
 
Protein Sciences Corporation
Attention: Drs Manon M. J. Cox, MBA
1000 Research Parkway
Meriden, CT 06450-7159
 
Dear Drs Cox:
 
We received your August 24, 2009, amendment to your biologics license application (BLA) submitted under section 351 of the Public Health Service Act (42 U.S.C. 262) for Influenza Vaccine on August 25, 2009.
 
We consider your submission a major amendment under the reauthorization of the prescription drug user fee program in the Food and Drug Administration Amendments Act of 2007.
 
Because we received this major amendment within three months of the action due date, we will add an additional three months to the time by which we should complete our review. Therefore, the action due date is January 27, 2010.
 
If you have any questions, please contact Regulatory Project Manager, Captain Katherine Matrakas, at (301)-827-3070.
 
Sincerely yours,
 
 /s/
 
Wellington Sun, M.D.
Director
Division of Vaccines and
 Related Products Applications
Office of Vaccines
 Research and Review
Center for Biologics
 Evaluation and Research
-
-